BREAST SURGERY PROGRESS TEST Name:

Similar documents
Breast Cancer. Most common cancer among women in the US. 2nd leading cause of death in women. Mortality rates though have declined

Breast Cancer. Saima Saeed MD

Breast Cancer. Dr. Andres Wiernik 2017

It is a malignancy originating from breast tissue

Classification System

Case Scenario 1 History and Physical 3/15/13 Imaging Pathology

Educational Goals and Objectives for Rotations on: Breast, Wound and Plastic Surgery

Excerpts from the American College of Surgeons Educational Courses about Breast Disease:

Case Scenario 1. 2/15/2011 The patient received IMRT 45 Gy at 1.8 Gy per fraction for 25 fractions.

Case Scenario 1: This case has been slightly modified from the case presented during the live session to add clarity.

ANNEX 1 OBJECTIVES. At the completion of the training period, the fellow should be able to:

General Information Key Points

Breast Cancer. Excess Estrogen Exposure. Alcohol use + Pytoestrogens? Abortion. Infertility treatment?

Breast Cancer Diagnosis, Treatment and Follow-up

Benign Breast Disease. David Anderson, MD Assistant Professor of Clinical Surgery

For more information about how to cite these materials visit

Case Scenario 1: This case has been slightly modified from the case presented during the live session to add clarity.

Certified Breast Care Nurse (CBCN ) Test Content Outline (Effective 2018)

Breast Cancer Screening and Treatment Mrs Belinda Scott Breast Surgeon Breast Associates Auckland

Lesion Imaging Characteristics Mass, Favoring Benign Circumscribed Margins Intramammary Lymph Node

Breast Cancer Update 2018 The Latest in Diagnosis and Treatment SARATH K, PALAKODETI, DO, FAACS GENERAL, BREAST, AND COSMETIC SURGEON TOLEDO CLINIC

What is Cancer? Petra Ketterl, MD Medical Oncology and Functional Medicine

Case 1. BREAST CANCER From Diagnosis to Treatment: The Role of Primary Care

Breast Cancer: Selected Topics for the Primary Care Clinician

COMMON BENIGN DISORDERS AND DISEASES OF THE BREAST

BREAST CANCER BREAST CANCER

Index. Note: Page numbers of article titles are in boldface type.

Breast Evaluation & Management Guidelines

BREAST PATHOLOGY. Fibrocystic Changes

Case #1: 75 y/o Male (treated and followed by prostate cancer oncology specialist ).

Breast Imaging: Multidisciplinary Approach. Madelene Lewis, MD Assistant Professor Associate Program Director Medical University of South Carolina

Breast Cancer Basics. Clinical Oncology for Public Health Professionals. Ben Ho Park, MD, PhD

Breast Surgery When Less is More and More is Less. E MacIntosh, MD June 6, 2015

ACRIN 6666 Therapeutic Surgery Form

Q&A. Fabulous Prizes. Collecting Cancer Data: Breast 4/4/13. NAACCR Webinar Series Collecting Cancer Data Breast

Evolving Practices in Breast Cancer Management

Breast Cancer FAQ. How does Breast Cancer spread? Breast cancer spreads by invading into

Jose A Torres, MD 1/12/2017

Basement membrane in lobule.

ABSITE Review. RTC Conference Christina Bailey January 15, 2009

Diseases of the breast (2 of 2) Breast cancer

Breast pathology. 2nd Department of Pathology Semmelweis University

DISORDERS OF THE BREAST Dated. FIBROADENOSIS Other common names: mastitis, fibrocystic disease, cystic mammary dysplasia.

BREAST CANCER SURGERY. Dr. John H. Donohue

Breast Cancer Risk Assessment and Prevention

Advances in Breast Surgery. Catherine Campo, D.O. Breast Surgeon Meridian Health System April 17, 2015

4/13/2010. Silverman, Buchanan Breast, 2003

Mousa. Israa Ayed. Abdullah AlZibdeh. 0 P a g e

Maram Abdaljaleel, MD Dermatopathologist and Neuropathologist University of Jordan, School of Medicine

Case study 1. Rie Horii, M.D., Ph.D. Division of Pathology Cancer Institute Hospital, Japanese Foundation for Cancer Research

Invasive Papillary Breast Carcinoma

Timby/Smith: Introductory Medical-Surgical Nursing, 9/e

Malignant Breast disorders

Breast Update Therese Cusick MS MD FACS

Surgery for Breast Cancer

Breast Cancer Treatment at Fox Chase Make an Appointment or Request a Second Opinion FOX-CHASE

Breast Cancer? Breast cancer is the most common. What s New in. Janet s Case

So, we already talked about that recognition is the key to optimal treatment and outcome.

Quiz. b. 4 High grade c. 9 Unknown

Breast Health. Knowledge and self-awareness are powerful tools. Understanding and utilizing these tools starts with

Breast Cancer Screening and Surgery. April 26, 2018 Ashley B. Simpson, DO

Presented by: Lillian Erdahl, MD

Ductal Carcinoma-in-Situ: New Concepts and Controversies

Recent advances in breast cancers

RUTGERS CANCER INSTITUTE OF NEW JERSEY - ROBERT WOOD JOHNSON MEDICAL SCHOOL INTERDISCIPLINARY BREAST SURGERY FELLOWSHIP CORE EDUCATIONAL OBJECTIVES

BREAST CANCER. Dawn Hershman, MD MS. Medicine and Epidemiology Co-Director, Breast Program HICCC Columbia University Medical Center.

Breast Cancer Pathway Map

BREAST PATHOLOGY MCQS

SIGNIFICANT OTHERS. Miscellaneous Benign Breast Conditions

Types of Breast Cancer

Breast Disease: What PCPs Need to Know. Eunice Cho MD FACS

Breast Cancer. What is breast cancer?

My Personalized Breast Cancer Worksheet

Health Bites Breast Cancer. Breast Cancer. Normal breast

ROLE OF MRI IN SCREENING, DIAGNOSIS AND MANAGEMENT OF BREAST CANCER. B.Zandi Professor of Radiology

BREAST SURGERY - SYLLABUS 2014

A712(18)- Test slide, Breast cancer tissues with corresponding normal tissues

Handout for Dr Allison s Lectures on Grossing Breast Specimens:

Breast Cancer: Current Approaches to Diagnosis and Treatment

Debate Axillary dissection - con. Prof. Dr. Rodica Anghel Institute of Oncology Bucharest

Imaging in breast cancer. Mammography and Ultrasound Donya Farrokh.MD Radiologist Mashhad University of Medical Since

National Center of Oncology - Yerevan, Armenia

04/10/2018. Intraductal Papillary Neoplasms Of Breast INTRADUCTAL PAPILLOMA

So, Who are the appropriate individuals that should consider genetic counseling and genetic testing?

Breast Cancer Imaging

A breast lump or thickening that feels different from the surrounding tissue

CPC 4 Breast Cancer. Rochelle Harwood, a 35 year old sales assistant, presents to her GP because she has noticed a painless lump in her left breast.

Armed Forces Institute of Pathology.

Evaluation of the Axilla Post Z-0011 Trial New Paradigm

Barlavento Medical Centre - Portimão, Portugal

Mammography and Other Screening Tests. for Breast Problems

Breast Cancer. Common kinds of breast cancer are

制定阮綜合醫療社團法人阮綜合醫院乳癌 (Breast Cancer) 治療共識

University of Washington Radiology Review Course: Strange and Specific Diagnoses. Case #1

DIAGNOSIS. Biopsy, Pathology and Subtypes. Knowledge Summary

Overview. Who Gets Breast Cancer? Breast cancer can strike anyone, although it does tend to follow particular trends.

AMSER Case of the Month: November 2018

Kay Tilton, RN, Certified Breast Care Nurse Breast Nurse Navigator Seattle Cancer Care Alliance September 20, 2016

Breast Imaging! Ravi Adhikary, MD!

Quality ID #263: Preoperative Diagnosis of Breast Cancer National Quality Strategy Domain: Effective Clinical Care

Transcription:

General Surgery Residency Program Excellent surgeons BREAST SURGERY PROGRESS TEST Name: Choose the BEST answer for the following questions. 1. All of the following factors are associated with an increased risk for the development of breast cancer EXCEPT: A atypical hyperplasia on breast biopsy B presence of BRCA1 defect C conjugated estrogen therapy after hysterectomy D increased bone density E increased breast density 2. A 42-year-old woman undergoes a stereotactic core biopsy of a 1-cm mammographically detected lesion in her left breast that demonstrates infiltrating ductal breast cancer (grade 2, ER/PR negative, HER2/neu positive). A paternal aunt had breast cancer at age 55 and a second paternal aunt had ovarian cancer at age 51. The next step in this patient's management should be: A MRI of both breasts B simple mastectomy with sentinel node biopsy C needle localization lumpectomy with sentinel node biopsy D genetic counseling E neoadjuvant chemotherapy 3. A 14-year-old girl presents with a 6-month history of sudden, rapid, asymmetric enlargement of the right breast. On physical examination, there is a large palpable mass occupying the breast with marked nipple-areolar stretching, prominent dilated veins, and skin ulceration. Mammography and ultrasonography show a dense, well-circumscribed 7-cm homogenous mass occupying the left breast. The most likely diagnosis is: A invasive ductal carcinoma B hemangioma C giant fibroadenoma D juvenile breast hypertrophy E phyllodes tumor Page 1 of 9

4. A patient undergoes a segmental mastectomy and negative margins are obtained. Two sentinel lymph nodes are identified. On final histologic evaluation, a 6-mm region of macrometastases is found on H&E staining within two of the lymph nodes. The next step should be: A completion mastectomy B completion axillary dissection C axillary dissection and breast radiation therapy D systemic chemotherapy alone E no further axillary operation 5. A 38-year-old woman has a 1.5-cm mass in her left breast. Clinical examination reveals no suspicious adenopathy. Mammogram-guided biopsy demonstrates infiltrating ductal carcinoma. The patient would prefer a lumpectomy followed by radiation therapy. Which of the following statements about sentinel lymph node biopsy (SLNB) is TRUE: A It is only indicated in women with a clinically positive axilla B It is associated with a survival advantage over routine axillary dissection C Neoadjuvant chemotherapy does not affect reliability of SLNB D It is best performed with blue dye alone E It is not indicated because of her premenopausal status 6. Which of the following statements about HER2/neu is TRUE: A Overexpression is ideally determined from the leukocyte DNA B It is an oncogene located on the long arm of chromosome 17 C It is a transmembrane, surface-bound Toll-like receptor D It has been designated as a CD340 (cluster of differentiation) and Erb-2 protein E Overexpression in breast cancer increases response to anthracyclines compared with other breast tumors 7. Which of the following statements BEST describes the activity of trastuzumab (Herceptin): A It is a humanized, monoclonal antibody agains the extracellular domain of the Erb-2 protein B Blinding of the cell surface receptor with the agent produces phosphorylation of the tyrosine kinase portion of the receptor C The agent is equally effective for treating testicular germ cell tumors that express overamplification of the HER2/neu gene D Tumors exposed to trastuzumab undergo arrest in the M phase of cell proliferation E Breast cancers that do not overexpress HER2/neu respond to high doses of trastuzumab Page 2 of 9

8. A 34-year-old trucker presents with the lesion shown. He says the problem began with an "infection" under the areola about 3 weeks ago. He was treated with antibiotics, which he took for 10 days and which improved his breast tenderness. Two days ago, spontaneous drainage from the opening as depicted occurred. He says he has had breast "infections" in the past. He has no other pertinent medical history. He is a heavy smoker. The most likely diagnosis is: A Paget s disease B atypical mycobacterium infection C granulomatous mastitis D inflammatory carcinoma E periductal mastitis 9. Breast cancer is diagnosed in a 28-year-old nulliparous woman who wishes to have children. Which of the following statements about her care is TRUE: A Mastectomy rather than partial mastectomy is the preferred surgical treatment B The chance of regular menstrual cycles returning after completion of chemotherapy correlates inversely with age C Future pregnancy and childbirth should be avoided D Embryo harvesting and/or cryopreservation should be postponed until after completion of cytotoxic chemotherapy E Tamoxifen will not affect her ability to conceive 10. A postmenopausal woman chooses mastectomy and sentinel lymph node biopsy (SLNB) for a new diagnosis of breast carcinoma. Final pathology reveals a 1-cm infiltrating ductal carcinoma with negative SLN; it is estrogen receptor/progesterone receptor (ER/PR) positive and HER2/neu negative. The most appropriate adjuvant therapy would be: A aromatase inhibitor B tamoxifen C postoperative breast radiation therapy D prophylactic oophorectomy E cytotoxic chemotherapy Page 3 of 9

11. Which of the following statements about lobular carcinoma in situ (LCIS) is NOT true: A Tamoxifen decreases the risk of invasive cancer B Patients have an increased risk of breast cancer bilaterally C Calcifications or a palpable mass are usually absent D Resection with negative margins is required E It is most common in premenopausal women 12. A 34-year-old woman in her 14th week of gestation has a 2.5-cm invasive ductal carcinoma. There are no palpable lymph nodes. The best treatment now would be: A modified radical mastectomy, adjuvant chemotherapy B modified radical mastectomy, radiotherapy, adjuvant chemotherapy C modified radical mastectomy D lumpectomy with axillary lymph node dissection, adjuvant chemotherapy E lumpectomy with sentinel lymph node biopsy, radiotherapy 13. Sentinel lymph node biopsy (SLNB) is NOT recommended for patients with: A invasive lobular carcinoma B prior excisional biopsy of the tumor C inflammatory breast cancer D male breast cancer E multicentric breast cancer 14. Which of the following statements about breast cancer in men is MOST accurate: A African American men have a better prognosis than white men B Klinefelter s syndrome (XXY) is associated with reduced risk of male breast cancer C The risk of contralateral breast cancer is higher in men than women D Breast cancer in men presents at an earlier age than in women E Men have a worse prognosis than women 15. A 55-year-old man presents with a 2-month history of progressive unilateral breast enlargement. He takes no medications and does not drink or smoke. On examination, he has a firm, tender, left-sided concentric subareolar mass. The remainder of his examination is normal. The next step in his diagnostic work-up should be: A fine-needle aspiration B treatment with oral antibiotics C mammography D ACTH measurement E serum testosterone to estradiol ratio 16. Which of the following statements about wound seromas after breast surgery is TRUE: A Seromas occur in 75% of patients having major breast surgery B Daily aspirations resolve seromas more quickly than aspirations only for symptoms C Intraoperative local wound application of tetracycline increases seroma formation D Iodine toxicity has been reported when povidone iodine is used as a sclerosing agent E Drain placement after one aspiration is recommended Page 4 of 9

17. Compared with women, men with breast cancer: A are more likely to have ER/PR positive disease B have a better long-term prognosis C are more likely to have lobular carcinoma D rarely receive hormonal treatment E are not accurately staged with sentinel node biopsy 18. A 40-year-old premenopausal African American woman presents with a hard 4-cm mass in the upper outer quadrant of the left breast. Core biopsy reveals intermediate-grade infiltrating ductal carcinoma that is estrogen and progesterone receptor (ER/PR) negative. The patient is taken to the operating room for port placement and sentinel node biopsy prior to chemotherapy. The sentinel node shows isolated tumor cells. Which of the following statements about this patient is TRUE: A Her prognosis will be better if her tumor is HER2/neu negative B She is considered node positive C A 21 gene recurrence score is recommended D Preoperative chemotherapy will increase her chance for breast conservation therapy E Postoperative anastrozole (Arimidex) therapy will improve her outcome 19. A 35-year-old woman whose breast examination is normal has a family history of breast cancer. Her mother died of breast cancer at age 45. Her 40-year-old sister was recently diagnosed with breast cancer, and was found to be positive for BRCA1 mutation. Which of the following statements is TRUE: A If she is BRCA1 negative, she should be screened according to general population guidelines B A full sequencing test for BRCA1 is indicated C Screening with MRI alone is appropriate D She has an equal probability of BRCA1 and BRCA2 mutations E A formal genetic risk assessment will likely increase her psychological distress 20. A 30-year-old woman who is 20 weeks pregnant has a 2.5-cm dominant, slightly tender mass in the left breast. Biopsy shows grade II infiltrating ductal carcinoma. This patient should be advised that: A preoperative tamoxifen therapy is safe and effective B chemotherapy now is contraindicated C breast conservation is an option D sentinel node biopsy is significant risk to the fetus E she should avoid all future pregnancies 21. A postmenopausal woman with a new diagnosis of breast cancer in her left breast elects to undergo mastectomy. Which of the following statements about contralateral prophylactic mastectomy is TRUE: A Overall mortality is improved B There is a survival advantage for patients with higher stage cancers C The incidence of contralateral breast cancer is significantly reduced D Sentinel lymph node biopsy should be done bilaterally E Reconstruction should be delayed until final histopathology is available Page 5 of 9

22. A 51-year-old perimenopausal woman undergoes lumpectomy and sentinel lymph node biopsy for invasive ductal carcinoma. Pathology reveals a 1.0-cm grade II ER /PR positive, HER2/neu negative carcinoma. The lateral margin of the lumpectomy specimen is positive for carcinoma. An intramammary lymph node within the lumpectomy specimen is infiltrated with cancer. Her sentinel lymph node shows no evidence of cancer. The next step in her management should be: A testing the specimen for Oncotype DX B re-excision of lumpectomy margin C simple mastectomy D radiation therapy followed by tamoxifen E re-excision and axillary lymph node dissection 23. A 90-year-old woman who is wheelchair-bound due to chronic obstructive pulmonary disease (COPD) presents with the lesion shown. Core biopsy shows well-differentiated ER /PR positive invasive ductal carcinoma. Physical examination demonstrates no palpable axillary adenopathy. The next step in her management should be: A modified radical mastectomy B radiation therapy C chemotherapy with adriamycin/cytoxan D aromatase inhibitors E wide local excision and sentinel lymph node biopsy 24. Breast MRI screening is appropriate for all of the following women EXCEPT: A 40-year-old BRCA2 mutation carrier B 55-year-old with scattered fibroglandular breast tissue on negative screening mammography C 38-year-old 13 years after mantle radiation therapy for Hodgkin s disease with normal clinical breast examination D 45-year-old with a 28% lifetime risk of breast cancer E 42-year-ol sister of BRCA1 mutation who has refused genetic testing Page 6 of 9

25. An asymptomatic 53-year-old woman undergoes an ultrasound-guided core needle biopsy for a new nonpalpable right breast nodule detected on mammography. Pathology demonstrates a papilloma with atypia. The next step in management should be: A tamoxifen for 5 years B raloxifene (Evista) for 5 years C dye-directed central duct excision D wire localization right breast excisional biopsy E observation 26. A 42-year-old woman presents with the acute onset of erythema and edema in her left breast. She was treated with oral antibiotics for 10 days without resolution of symptoms. Mammography shows skin edema and a masslike area at 12 o'clock in her left breast. Core and punch biopsies demonstrate infiltrating carcinoma, grade III ER/PR negative, HER2/neu 3+(FISH positive). The next step in treatment should be: A simple mastectomy and sentinel node biopsy B modified radical mastectomy C whole breast irradication D neoadjuvant hormonal therapy E neoadjuvant chemotherapy and monoclonal antibody infusion 27. An asymptomatic premenopausal 45-year-old woman undergoes lumpectomy and sentinel node biopsy for a grade III, 0.9-cm ER/PR positive, HER2/neu negative infiltrating ductal carcinoma. All four sentinel nodes are negative and the closest surgical margin is 5 mm. Her Ki-67 is 3+, 56%. The next step in management should be: A PET scan B topoisomerase II alpha gene analysis C Oncotype Dx assay D bilateral whole breast ultrasound E bone scan 28. Which of the following statements about the role of operation for patients presenting with synchronous stage IV breast cancer is TRUE: A Resection of the primary site to a free margin may improve survival B Resection of metastatic disease sites does not improve survival C The primary site and progression-free survival do not affect the timing of operation D Palliative resections for symptom control are increasing E Survival is not affected by the site of distant metastases Page 7 of 9

29. An 86-year-old woman undergoes lumpectomy and sentinel node biopsy, followed by external-beam radiation therapy, for an ER/PR negative, HER2/neu negative 3-cm node-negative infiltrating ductal carcinoma. Eight years later, she presents with the breast changes pictured. Which of the following statements about her disease process is NOT true: A Positive immunochemical staining for CD31 assists with the diagnosis B The average time for appearance of this lesion varies from 3 to 12 years after initial operation C Chemotherapeutic agents are routinely used after resection D The most common site of metastasis is lung E Wide surgical excision is recommended 30. Needle localization lumpectomy required for lesions identified on core biopsy: A Lobular carcinoma in situ (LCIS) B Atypical ductal hyperplasia (ADH) 31. Part of spectrum of histologic transformation of ductal epithelium from normal tissue to invasive breast cancer: A Lobular carcinoma in situ (LCIS) B Atypical ductal hyperplasia (ADH) 32. Increased risk of developing breast: A Lobular carcinoma in situ (LCIS) B Atypical ductal hyperplasia (ADH) Page 8 of 9

33. Associated with smoking: A Idiopathic granulomatous mastisis (IGM) B Periductal mastisis (PDM) 34. Associated with pregnancy within 5 years of: A Idiopathic granulomatous mastisis (IGM) B Periductal mastisis (PDM) 35. Radiation therapy: A Idiopathic granulomatous mastisis (IGM) B Periductal mastisis (PDM) SCORE: /35 Page 9 of 9